Skip to content
Open access

Integrative machine learning identifies ECM1 as a candidate autophagy-related biomarker for immune infiltration and prognosis in hepatocellular carcinoma

Aug 2026 · Discover Oncology · 0 citations

Abstract

Hepatocellular carcinoma (HCC) remains one of the leading causes of cancer-related mortality worldwide and exhibits substantial molecular heterogeneity, highlighting the need for reliable prognostic biomarkers and therapeutic targets. Increasing evidence suggests that autophagy plays a critical role in HCC progression. This study aimed to identify autophagy-related candidate biomarkers associated with prognosis and immune infiltration in HCC using an integrative machine learning and bioinformatics approach. Gene expression profiles from the GEO datasets GSE121248 and GSE64041 were analyzed to identify differentially expressed genes (DEGs) between HCC and normal liver tissues. Autophagy-related DEGs (ARDEGs) were identified by intersecting DEGs with the Human Autophagy Database, Molecular Signatures Database and GeneCards. Functional enrichment analyses (GO and KEGG) were performed to characterize their biological functions. Clinical information, including overall survival (OS), was obtained from the TCGA-LIHC cohort. Three machine learning algorithms, LASSO Cox regression, Random Survival Forest (RSF), and Support Vector Machine Recursive Feature Elimination (SVM-RFE), were applied to prioritize prognostically relevant genes followed by external validation. Integrated analyses of gene expression, clinicopathological characteristics, immune cell infiltration, transcription factor–miRNA regulatory networks, and drug–gene interactions were subsequently performed. Sixteen autophagy-related DEGs were identified and were significantly enriched in longevity regulation, FoxO signaling, and AMPK signaling pathways. Integrating the results from LASSO Cox regression, RSF, and SVM-RFE identified six candidate prognostic genes: ECM1, EZH2, KLF4, CDH1, FAS, and GABARAPL1. Among these, ECM1 emerged as the primary candidate for further investigation because of its distinctive association with autophagy-related gene signatures, epithelial–mesenchymal transition (EMT), immune infiltration, and overall survival. Notably, ECM1 exhibited reduced expression in HCC while displaying altered correlations with autophagy-related genes compared with normal liver tissue, suggesting a potential disruption of its regulatory network during hepatocarcinogenesis. This integrative computational study identified six autophagy-related candidate prognostic genes in HCC and prioritized ECM1 as a promising candidate for future mechanistic investigation. The observed associations between ECM1, autophagy, immune infiltration, and patient prognosis provide a rationale for further experimental studies to determine its biological role and evaluate its potential clinical relevance. The findings should be considered hypothesis-generating until validated in independent experimental and clinical studies.

Read PDF

Similar papers

Open access Sep 2026

Macrophage-linked lipid metabolic signatures for HCC prognosis identified through integrated bulk and single-cell transcriptomics

Background Macrophage-dependent immune remodeling and altered lipid metabolism are closely related to liver cancer behavior. In hepatocellular carcinoma (HCC), the survival relevance of macrophage-associated lipid metabolism genes (MLMGs) remains insufficiently characterized. This work evaluated MLMG-related molecular...

Yu Yang, Man-Man Lu, Huapeng Zhang et al. · 0 citations
Open access Sep 2026

Identification of FN1 and TIMP1 as macrophage-associated programmed cell death-related prognostic markers in glioblastoma via integrated bulk and single-cell RNA sequencing

The risk model based on FN1 and TIMP1 are identified as pivotal MacPCD-related prognostic genes in GBM, offering a reliable tool for clinical prognosis and paving the way for personalized immunotherapy strategies.

Feng Li, Cai-Feng Wang, Zhe-Sen Tian et al. · 0 citations
Aug 2026

CCT6B as a candidate chaperonin-related molecule in hepatocellular carcinoma: Bioinformatic analysis and preliminary experimental validation.

PURPOSE Hepatocellular carcinoma (HCC) is an aggressive malignancy with limited therapeutic options and poor prognosis, highlighting the need for prognostic biomarkers and novel molecular candidates. This study aimed to identify chaperonin-related genes associated with HCC prognosis and to preliminarily explore the bio...

Li Su, Meng-Si Wu, Hua Liu et al. · 0 citations
Open access Aug 2026

Identification of acetylation-related gene biomarkers for gallbladder carcinoma via multi-dataset and machine learning, with insights into immune microenvironment modulation

This study systematically characterizes acetylation-related genes in GBC, develops a high-accuracy diagnostic model, and provides preliminary insights into potential links between epigenetic regulation and the immune microenvironment.

Yecheng Wang, Dong-bin Liu, Yamin Zheng et al. · 0 citations
Open access Aug 2026

Integrated Transcriptomic Analyses Identify Four Prognosis-Associated Genes in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is one of the malignant tumors with high incidence and mortality rates worldwide. Given the poor prognosis of patients with HCC, it is crucial to explore the molecular mechanisms underlying HCC development and to evaluate prognostic markers. Differential expression analysis followed by un...

Yu-Xian Liu, Xing-Jie Chen, Jun-Yuan Zhang et al. · 0 citations
Open access Aug 2026

Glycolysis and T cell-associated gene signature predicts prognosis and therapeutic responses in pancreatic cancer

In vitro and in vivo experiments demonstrated that GPR87 knockdown inhibits the proliferation, migration, and clonogenic ability of PC cells while promoting their apoptosis, providing preliminary hypothesis-generating insights that require validation in independent institutional or prospective clinical cohorts before a...

Wan-Cheng Li, Dong-Ao Fan, Yan Du et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.